Purification and identification of Angiotensin-I Converting Enzyme (ACE) inhibitory peptide from lizard fish (Saurida elongata) hydrolysate

Shanguang Wu,Xuezhen Feng,Xiongdiao Lan,Yuanjin Xu,Dankui Liao
DOI: https://doi.org/10.1016/j.jff.2014.12.051
IF: 5.6
2015-01-01
Journal of Functional Foods
Abstract:Lizard fish (Saurida elongata) muscle protein was hydrolyzed by neutral protease to obtain the hydrolysate with angiotensin-I converting enzyme (ACE) inhibitory activity. A novel ACE inhibitory peptide was successfully purified from Lizard fish protein hydrolysate (LFPH) by ultrafiltration, size exclusion chromatography, and high-performance liquid chromatography (HPLC). The amino acid sequence of the purified peptide was identified as Arg-Val-Cys-Leu-Pro (RVCLP) and in vitro ACE inhibitory activity assay revealed an IC50 value of 175 µM. Our study suggests that peptide from lizard fish hydrolysate may be beneficial as antihypertensive compounds for use as functional food ingredients or pharmaceuticals against hypertension.
What problem does this paper attempt to address?